NCT07373938Recruiting
Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus
Carotid Wall Layer Texture as a Potential Biomarker for Cardiovascular Risk Assessment in Preventive Nursing: a Study in Type 2 Diabetes Mellitus
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
This study aims to compare carotid intima-media thickness (CIMT) and layer-specific texture characteristics of the carotid wall between individuals with Type 2 diabetes mellitus (T2DM) and normoglycemic controls, to assess the impact of T2DM on these ultrasound variables and evaluate their ability to discriminate between low and high cardiovascular risk at 10 years.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 20 Jan 2026
- Start date
- 25 Jan 2026
- Primary completion date
- 28 Jan 2026
- Lead sponsor
- Cardenal Herrera University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07373938
What you commit to
- Study type: Observational
- Planned participants: 80
- From 25 Jan 2026 to the primary completion date, 28 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of clinical cardiovascular disease (secondary prevention).
- Type 1 diabetes mellitus.
- Patients with established severe target organ damage or conditions that automatically classify them as very high cardiovascular risk according to ESC guidelines.
- Advanced chronic kidney disease (estimated glomerular filtration rate \<30 mL/min/1.73 m²).
Who the study is looking for
- European adults.
- Age between 40 and 69 years.
- Confirmed diagnosis of type 2 diabetes mellitus.
- No established cardiovascular disease.
- Availability of the required clinical and metabolic variables: Age; Sex; Systolic blood pressure; Non-high-density lipoprotein (non-HDL) cholesterol; Smoking status; Duration of diabetes; Glycated hemoglobin (HbA1c); Presence or absence of diabetes-related target organ damage (e.g., albuminuria, retinopathy)
Age in the registry: 40 years to 69 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Francisco Javier Molina Payá Coordinator of this site? Confirm its status | Elche | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.